inews.co.uk on MSN
Chronic UTI sufferers look forward to first new antibiotic in decades
The first new antibiotic for UTIs in nearly 30 years has been approved by regulators. Gepotidacin, also known as Blujepa, is ...
All of this disproportionately affects the elderly. In a 2023 study of patients with a median age of 75, approximately 30% of ...
If you’ve ever had a UTI, a.k.a. a urinary tract infection, you know the agony that often comes with one: peeing (what feels like) shards of glass and constantly feeling like you have to go, even when ...
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...
Credit: Getty Images. Results are from a meta-analysis of 33 trials involving 35,939 patients with overactive bladder. Overactive bladder treatment using antimuscarinic drugs increases the risks for ...
A woman who has endured the pain of urinary tract infections (UTIs) all her adult life has welcomed the news that 99% of pharmacies in Wales will now able to treat the condition without a visit to the ...
Urinary tract infections (UTIs) are increasingly common in men, especially with age, posing serious health risks like blood ...
Urinary tract infections are common, and the risk generally increases with age. They happen when bacteria infect your urethra, bladder, or other organs in your urinary tract. In older people, UTIs ...
Antibiotics do not cause urinary tract infections (UTIs). However, research suggests there may be a link between prior use of antibiotics and a person developing an antibiotic-resistant UTI. A UTI may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results